Summit Therapeutics Inc. Common Stock trailing returns
Summit Therapeutics Inc. Common Stock's 10-year return is +0.2% a year (CAGR) (+1.6% cumulative). How Summit Therapeutics Inc. Common Stock (SMMT) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
Data provided bySource: Twelve DataTo 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| Cumulative · the change over the window | ||||
| 1 day | -9.7% | +0.0% | -9.7% | — |
| 5 days | -40.2% | +0.0% | -40.2% | -40.2%Nov 17 |
| 1 month | -27.1% | +0.0% | -27.1% | -40.2%Nov 17 |
| YTD | -39.0% | +0.0% | -39.0% | -59.6%Nov 17 |
| Per year (CAGR) · the cumulative total return beneath | ||||
| 1 year | -37.1% | +0.0% | -37.1% CAGR | -59.6%Nov 2026 |
| 5 years | +14.5% | +0.0% | +14.5% CAGR+97.2% total | -87.6%Dec 2022 |
| 10 years | +0.2% | +0.0% | +0.2% CAGR+1.6% total | -95.8%Dec 2022 |
| Since 2015Since inception (2015) | +0.4% | +0.0% | +0.4% CAGR+4.7% total | -95.8%Dec 2022 |
Growth of SMMT#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+14.5%/year · +97.2%
- 10 years+0.2%/year · +1.6%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in SMMT's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Summit Therapeutics Inc. Common Stock's 10-year return?
- Over the last 10 years, Summit Therapeutics Inc. Common Stock (SMMT) returned about +0.2% a year annualized (+1.6% cumulative total return).
- What is Summit Therapeutics Inc. Common Stock's return since inception?
- Since 2015, Summit Therapeutics Inc. Common Stock (SMMT) has compounded at about +0.4% a year — +4.7% in total.
